» Articles » PMID: 36676026

Potential Properties of Natural Nutraceuticals and Antioxidants in Age-Related Eye Disorders

Abstract

Eye health is crucial, and the onset of diseases can reduce vision and affect the quality of life of patients. The main causes of progressive and irreversible vision loss include various pathologies, such as cataracts, ocular atrophy, corneal opacity, age-related macular degeneration, uncorrected refractive error, posterior capsular opacification, uveitis, glaucoma, diabetic retinopathy, retinal detachment, undetermined disease and other disorders involving oxidative stress and inflammation. The eyes are constantly exposed to the external environment and, for this reason, must be protected from damage from the outside. Many drugs, including cortisonics and antinflammatory drugs have widely been used to counteract eye disorders. However, recent advances have been obtained via supplementation with natural antioxidants and nutraceuticals for patients. In particular, evidence has accumulated that polyphenols (mostly deriving from Citrus Bergamia) represent a reliable source of antioxidants able to counteract oxidative stress accompanying early stages of eye diseases. Luteolin in particular has been found to protect photoreceptors, thereby improving vision in many disease states. Moreover, a consistent anti-inflammatory response was found to occur when curcumin is used alone or in combination with other nutraceuticals. Additionally, Coenzyme Q10 has been demonstrated to produce a consistent effect in reducing ocular pressure, thereby leading to protection in patients undergoing glaucoma. Finally, both grape seed extract, rich in anthocyanosides, and polynsatured fatty acids seem to contribute to the prevention of retinal disorders. Thus, a combination of nutraceuticals and antioxidants may represent the right solution for a multi-action activity in eye protection, in association with current drug therapies, and this will be of potential interest in early stages of eye disorders.

Citing Articles

The Role of Diet and Oral Supplementation for the Management of Diabetic Retinopathy and Diabetic Macular Edema: A Narrative Review.

DAngelo A, Lixi F, Vitiello L, Gagliardi V, Pellegrino A, Giannaccare G Biomed Res Int. 2025; 2025:6654976.

PMID: 40041571 PMC: 11876532. DOI: 10.1155/bmri/6654976.


Evidence for a Functional Link Between the Nrf2 Signalling Pathway and Cytoprotective Effect of S-Petasin in Human Retinal Pigment Epithelium Cells Exposed to Oxidative Stress.

Pizzoferrato M, Lazzarino G, Brancato A, Tabolacci E, Clementi M, Tringali G Antioxidants (Basel). 2025; 14(2).

PMID: 40002367 PMC: 11851853. DOI: 10.3390/antiox14020180.


Effects of Selected Antioxidants on Electroretinography in Rodent Diabetic Retinopathy.

Dutczak R, Pietrucha-Dutczak M Antioxidants (Basel). 2025; 14(1).

PMID: 39857355 PMC: 11762402. DOI: 10.3390/antiox14010021.


Health Benefits of Epigallocatechin Gallate and Forskolin with a Special Emphasis on Glaucoma and Other Retinal Diseases.

Rusciano D Medicina (Kaunas). 2025; 60(12.

PMID: 39768839 PMC: 11678229. DOI: 10.3390/medicina60121957.


Unraveling the mechanisms underlying diabetic cataracts: insights from Mendelian randomization analysis.

Liu W, Pan Y Redox Rep. 2024; 29(1):2420563.

PMID: 39639475 PMC: 11626871. DOI: 10.1080/13510002.2024.2420563.


References
1.
Stringham J, Stringham N . Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation. Exp Eye Res. 2016; 151:1-8. DOI: 10.1016/j.exer.2016.07.005. View

2.
Liu T, Liu W, Zhao J, Meng F, Wang H . Lutein protects against β-amyloid peptide-induced oxidative stress in cerebrovascular endothelial cells through modulation of Nrf-2 and NF-κb. Cell Biol Toxicol. 2016; 33(1):57-67. DOI: 10.1007/s10565-016-9360-y. View

3.
Chiambaretta F, Doan S, Labetoulle M, Rocher N, El Fekih L, Messaoud R . A randomized, controlled study of the efficacy and safety of a new eyedrop formulation for moderate to severe dry eye syndrome. Eur J Ophthalmol. 2016; 27(1):1-9. DOI: 10.5301/ejo.5000836. View

4.
Quinzii C, Lopez L, Gilkerson R, Dorado B, Coku J, Naini A . Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency. FASEB J. 2010; 24(10):3733-43. PMC: 2996902. DOI: 10.1096/fj.09-152728. View

5.
Nebbioso M, Franzone F, Greco A, Gharbiya M, Bonfiglio V, Polimeni A . Recent Advances and Disputes About Curcumin in Retinal Diseases. Clin Ophthalmol. 2021; 15:2553-2571. PMC: 8219301. DOI: 10.2147/OPTH.S306706. View